For instance, ATAD2 has been implicated in modulating the Rb/E2F axis that controls cell cycle progression, as well as oncogenic pathways such as PI3K/AKT and MAPK signaling, highlighting its potential to influence several regulatory networks that adapt during tumor progression. This evidence concerns the gene ATAD2 and neoplasm.